Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
3.470
+0.060 (1.76%)
At close: Aug 6, 2025, 4:00 PM
3.500
+0.030 (0.86%)
After-hours: Aug 6, 2025, 6:43 PM EDT
Verve Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.